[go: up one dir, main page]

NO20076592L - Stabilt aktivt-stoffkompleks av salter av o-acetylsalicylsyre med basiske aminosyrer og glycin - Google Patents

Stabilt aktivt-stoffkompleks av salter av o-acetylsalicylsyre med basiske aminosyrer og glycin

Info

Publication number
NO20076592L
NO20076592L NO20076592A NO20076592A NO20076592L NO 20076592 L NO20076592 L NO 20076592L NO 20076592 A NO20076592 A NO 20076592A NO 20076592 A NO20076592 A NO 20076592A NO 20076592 L NO20076592 L NO 20076592L
Authority
NO
Norway
Prior art keywords
glycine
salts
amino acids
active substance
basic amino
Prior art date
Application number
NO20076592A
Other languages
English (en)
Inventor
Gerhard Franckowiak
Wolfram Ledwoch
Yutaka Hayauchi
Eberhard Schweinheim
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36649662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20076592(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of NO20076592L publication Critical patent/NO20076592L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det er beskrevet stabile aktivt stofikomplekser av salter av o-acetylsalisylsyre med basiske aminosyrer og glysin, en fremgangsmåte for fremstilling derav og deres anvendelse som medikamenter.
NO20076592A 2005-06-02 2007-12-20 Stabilt aktivt-stoffkompleks av salter av o-acetylsalicylsyre med basiske aminosyrer og glycin NO20076592L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005025283A DE102005025283A1 (de) 2005-06-02 2005-06-02 Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
PCT/EP2006/004799 WO2006128600A2 (de) 2005-06-02 2006-05-20 Stabiler wirkstoffkomplex von salzen der o-acetylsalicylsäure mit basischen aminosäuren und glycin

Publications (1)

Publication Number Publication Date
NO20076592L true NO20076592L (no) 2007-12-20

Family

ID=36649662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076592A NO20076592L (no) 2005-06-02 2007-12-20 Stabilt aktivt-stoffkompleks av salter av o-acetylsalicylsyre med basiske aminosyrer og glycin

Country Status (32)

Country Link
US (1) US8063243B2 (no)
EP (1) EP1890994B1 (no)
JP (1) JP2008542316A (no)
KR (1) KR101347522B1 (no)
CN (1) CN101248036B (no)
AR (1) AR057341A1 (no)
AT (1) ATE526974T1 (no)
AU (1) AU2006254429B2 (no)
BR (1) BRPI0610734A2 (no)
CA (1) CA2610194C (no)
CR (1) CR9556A (no)
CY (1) CY1112185T1 (no)
DE (1) DE102005025283A1 (no)
DK (1) DK1890994T3 (no)
ES (1) ES2373917T3 (no)
HR (1) HRP20120003T1 (no)
IL (1) IL187772A (no)
MA (1) MA29604B1 (no)
MX (1) MX2007014988A (no)
NO (1) NO20076592L (no)
NZ (1) NZ563871A (no)
PL (1) PL1890994T3 (no)
PT (1) PT1890994E (no)
RS (1) RS52111B (no)
RU (1) RU2433995C2 (no)
SG (1) SG162744A1 (no)
SI (1) SI1890994T1 (no)
TN (1) TNSN07452A1 (no)
TW (1) TWI374740B (no)
UA (1) UA89827C2 (no)
WO (1) WO2006128600A2 (no)
ZA (1) ZA200710251B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008004386A1 (de) * 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
AU2010263409B2 (en) * 2009-06-25 2013-09-05 Tetra, Sia Novel acetylsalicylic acid salts
CA2766048A1 (en) 2009-06-25 2010-12-29 Tetra, Sia Novel acetylsalicylic acid salts
FR2965261B1 (fr) * 2009-09-30 2012-10-26 Holis Technologies Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
FR2950625B1 (fr) * 2009-09-30 2016-12-02 Holis Tech Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue
TWI478715B (zh) * 2010-12-03 2015-04-01 Tetra Sia 新穎乙醯柳酸鹽
RU2011132483A (ru) * 2011-08-02 2013-02-10 Елена Александровна Моренко Биологически активный продукт для применения в ветеринарии и животноводстве, способ его получения и способы повышения выживаемости, стимуляции роста, иммуностимуляции и повышения общей неспецифической резистентности организма сельскохозяйственных животных
CN102503845A (zh) * 2011-09-28 2012-06-20 广州普星药业有限公司 一种dl-赖氨酸阿司匹林盐的制备方法及其应用
ITMI20121144A1 (it) * 2012-06-28 2013-12-29 Dipharma Francis Srl Procedimento per la preparazione di un sale di un farmaco antinfiammatorio non steroideo
LV14963B (lv) 2013-06-28 2015-10-20 Tetra, Sia Endoteliālās disfunkcijas korektors
WO2017144149A1 (de) * 2016-02-23 2017-08-31 Merck Patent Gmbh Glycin-partikel
DK3558920T3 (da) * 2016-12-23 2021-07-05 Aspiair Gmbh Forbedret syntese af lysinacetylsalicylat-glycin-partikler
CA3064012A1 (en) 2017-05-30 2018-12-06 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)
CN112592286B (zh) * 2020-11-23 2024-02-02 蚌埠丰原医药科技发展有限公司 一种阿司匹林与碱性氨基酸的络合物的制备方法
JP2025501974A (ja) 2022-01-05 2025-01-24 アスピエアー ゲーエムベーハー アセチルサリチル酸リジン・グリシン粒子の改良された合成

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
JPS5665816A (en) * 1979-11-01 1981-06-03 Green Cross Corp:The Acetylsalicylate pharmaceutical for injection
US4446132A (en) * 1982-03-11 1984-05-01 Dynatech Laboratories Incorporated Nontoxic aspirin composition
CS247688B1 (cs) * 1984-12-22 1987-01-15 Evzen Kasafirek Způsob výroby soli lysinu s kyselinou acetylsalicylovou
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
FR2741534B1 (fr) * 1995-11-23 1998-09-11 Mazal Pharma Composition pharmaceutique stable a base d'acide acetylsalicylique et de tocopherol
JPH11222425A (ja) * 1997-10-27 1999-08-17 Ss Pharmaceut Co Ltd 関節疾患治療用関節内投与製剤
DE10034802A1 (de) 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
RU2203064C2 (ru) * 2001-03-11 2003-04-27 Каменев Виктор Федорович Способ лечения аспириновой бронхиальной астмы
DE10202019A1 (de) * 2002-01-18 2003-07-24 Bayer Ag Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
DE102004025535A1 (de) * 2004-05-25 2005-12-22 Bayer Healthcare Ag Kombination von Salzen der o-Acetylsalicylsäure und Alpha-Glucosidase-Inhibitoren

Also Published As

Publication number Publication date
AU2006254429B2 (en) 2011-11-10
AU2006254429A1 (en) 2006-12-07
CA2610194A1 (en) 2006-12-07
IL187772A (en) 2013-06-27
ES2373917T3 (es) 2012-02-10
CR9556A (es) 2008-03-03
ATE526974T1 (de) 2011-10-15
CA2610194C (en) 2013-11-05
RS52111B (en) 2012-08-31
MX2007014988A (es) 2008-02-15
TW200716138A (en) 2007-05-01
BRPI0610734A2 (pt) 2010-07-20
EP1890994A2 (de) 2008-02-27
IL187772A0 (en) 2008-08-07
RU2007148709A (ru) 2009-07-20
CN101248036A (zh) 2008-08-20
DK1890994T3 (da) 2012-02-06
ZA200710251B (en) 2009-09-30
MA29604B1 (fr) 2008-07-01
DE102005025283A1 (de) 2006-12-07
CN101248036B (zh) 2016-03-16
KR20080030578A (ko) 2008-04-04
KR101347522B1 (ko) 2014-01-02
TNSN07452A1 (en) 2009-03-17
HRP20120003T1 (hr) 2012-01-31
WO2006128600A2 (de) 2006-12-07
US8063243B2 (en) 2011-11-22
WO2006128600A3 (de) 2007-04-26
JP2008542316A (ja) 2008-11-27
PT1890994E (pt) 2012-01-05
NZ563871A (en) 2011-02-25
CY1112185T1 (el) 2015-12-09
EP1890994B1 (de) 2011-10-05
AR057341A1 (es) 2007-11-28
TWI374740B (en) 2012-10-21
SI1890994T1 (sl) 2012-02-29
RU2433995C2 (ru) 2011-11-20
UA89827C2 (ru) 2010-03-10
SG162744A1 (en) 2010-07-29
US20090226524A1 (en) 2009-09-10
PL1890994T3 (pl) 2012-03-30

Similar Documents

Publication Publication Date Title
NO20076592L (no) Stabilt aktivt-stoffkompleks av salter av o-acetylsalicylsyre med basiske aminosyrer og glycin
NO20085064L (no) 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
CY1118601T1 (el) Αλκυλαμινο-υποκατεστημενες δικυανοπυριδινες και προφαρμακα τυπου εστερα αμινοξεος αυτων
CY1112831T1 (el) Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh
TW200642700A (en) Chemically defined stabiliser
NO20083863L (no) Pyrazoler som 11-beta-hsd-1
NO20085066L (no) 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20085067L (no) 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
ATE420662T1 (de) Stabilisierte zubereitungen von serin- endopeptidasen, deren herstellung und verwendung
MY134521A (en) Stable salts of o-acetylsalicylic acid with basic amino acids
BR112014027244A2 (pt) derivados de benzamida para inibição da atividade de abl1, abl2 e bcr-abl1
WO2008099874A1 (ja) ピラジン誘導体を含有する医薬組成物およびピラジン誘導体を組み合わせて使用する方法
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
WO2007119001A3 (fr) Derives d 'aminomethyl pyridine, leur preparation et leur application en therapeutique
EA200701852A1 (ru) Производные аминокислот
NO20073549L (no) Fremgangsmate for fremstilling av organiske forbindelser
JO3684B1 (ar) صور متبلرة من الملح ثنائي الصوديوم لحمض n-(5-كلورو ساليسلويل)-8-امينو كابريليك
BR0307009A (pt) Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos ii
NZ591837A (en) Amino acid derivative
UA94042C2 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса
ATE366734T1 (de) Benzochinolizin-2-carbonsäureargininsalz- tetrahydrat
DK1585728T3 (da) Iminosyrederivater som inhibitorer af matrix-metalloproteinaser
WO2008115915A3 (en) Non-hygroscopic l-carnitine salts
NO20044629L (no) Fremgangsmate til fremstilling av sure salter av gemifloksasin.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application